Literature DB >> 31311421

Elastofibroma dorsi: a case report of bilateral occurrence and review of literature.

Glenn De Weerdt1, Veronique Verhoeven2, Ina Vrints1, Filip Thiessen1, Thierry Tondu1.   

Abstract

BACKGROUND: Elastofibroma dorsi (ED) is a benign slow growing soft tissue tumor that is most frequently located subscapular. The prevalence is estimated to be 2% on imaging studies in individuals over 60 years old and might occur bilaterally. The etiology, however, remains unclear. CASE
PRESENTATION: This report presents the case of a man with bilateral ED. He first presented at the age of 49 with a subscapular ED on the right side and again at the age of 53 with a subscapular ED on the left side. At both times, diagnosis of ED was histopathologically confirmed after surgical resection. And, again at both times, the postoperative course was characterized by seroma development. DISCUSSION: This report shows a brief review of literature on ED. It contains a summary of the current data on prevalence, etiology, clinical presentation, diagnosis, histopathological findings, surgical treatment and postoperative management. It also includes a flowchart for diagnostic and therapeutic approach.
CONCLUSIONS: ED might present bilaterally, though not necessarily affecting both sides simultaneously. In order to diagnose ED MRI is ought to be sufficient. Invasive procedures, i.e. complete surgical excision, are mandatory to treat symptomatic ED, although such surgical procedures are often complicated by seroma formation.

Entities:  

Keywords:  Elastofibroma dorsi; connective tissue; seroma; subscapular; tumor

Mesh:

Year:  2019        PMID: 31311421     DOI: 10.1080/00015458.2019.1642595

Source DB:  PubMed          Journal:  Acta Chir Belg        ISSN: 0001-5458            Impact factor:   1.090


  1 in total

1.  Elastofibroma dorsi: What's new?

Authors:  Maria Serena Oliva; Alessandro Smimmo; Raffaele Vitiello; Cesare Meschini; Francesco Muratori; Giulio Maccauro; Antonio Ziranu
Journal:  Orthop Rev (Pavia)       Date:  2020-07-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.